These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 9681807

  • 1. Reduced expression of tissue inhibitor of metalloproteinase in nodal metastasis of stomach cancer.
    Ko BK, Cho HR, Choi DW, Nam CW, Park CJ, Kim GY, Kim SS, Woo YJ, Huh J, Kim MY.
    J Korean Med Sci; 1998 Jun; 13(3):286-90. PubMed ID: 9681807
    [Abstract] [Full Text] [Related]

  • 2. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T.
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [Abstract] [Full Text] [Related]

  • 3. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
    Tanney DC, Feng L, Pollock AS, Lovett DH.
    Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.
    Kugler A, Hemmerlein B, Thelen P, Kallerhoff M, Radzun HJ, Ringert RH.
    J Urol; 1998 Nov; 160(5):1914-8. PubMed ID: 9783985
    [Abstract] [Full Text] [Related]

  • 6. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
    Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N, Okada Y.
    Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
    [Abstract] [Full Text] [Related]

  • 7. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].
    Li L, Zhang S, Lin H, Lin JY.
    Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.
    Moser PL, Hefler L, Tempfer C, Neunteufel W, Kieback DG, Gitsch G.
    Anticancer Res; 1999 Oct; 19(3B):2365-7. PubMed ID: 10472357
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
    Zhang S, Li L, Lin JY, Lin H.
    World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
    Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Reich R.
    Gynecol Oncol; 1999 Jun; 73(3):372-82. PubMed ID: 10366463
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
    Afzal S, Lalani el-N, Foulkes WD, Boyce B, Tickle S, Cardillo MR, Baker T, Pignatelli M, Stamp GW.
    Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.